Healthcare Technology Consultant/Contributing Writer
Keith Speights is a Healthcare Technology Consultant and Contributing Writer. He specializes in finance, personal finance, investment, and financial technology, often covering topics such as markets, business leaders, and government politics. Keith's work has been featured in prominent outlets including USA TODAY, Yahoo Finance, and The Motley Fool.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Keith Speights focuses on investment analysis, particularly in the stock market and personal finance, with a heavy emphasis on healthcare and pharmaceuticals. He cites data significantly in his articles.
When reaching out to Keith, consider offering insights or analyses related to investing strategies, dividend stocks, social security issues, retirement planning tips or developments in the healthcare and pharmaceutical sectors. Additionally, providing data-driven perspectives would likely resonate well with him given his frequent citation of data in his coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Keith Speights
Key Points Ackman bought his favorite AI stock -- Alphabet -- in the first quarter of 2023. Alphabet should have tremendous growth prospects in AI, cloud services, quantum computing, and robotaxis. The regulatory and competitive threats to Alphabet's business aren't worrisome at this point. Motley Fool Issues Rare “All In” Buy Alert
By: Keith Speights
Many people view Social Security as a plan that forces individuals to save for their retirement. Employers must contribute to the retirement savings of their workers, too. There's also a twist to Social Security that allows spouses to claim benefits based on their husbands' or wives' benefits.
By: Keith Speights
Key Points The SPDR S&P 500 ETF Trust is the biggest ETF in the world and the top holding in Buffett's secret portfolio. The iShares Core MSCI EAFE ETF, which owns stocks of companies operating in Europe, Australasia, and the Far East, is the second-largest position in Buffett's secret portfolio. The Vanguard High Dividend Yield is the third-largest holding in Buffett's secret portfolio. Motley Fool Issues Rare “All In” Buy Alert
A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly with those kinds of turbocharged performers.
By: Keith Speights
Key Points All three stocks are midstream energy leaders with exceptional yields. Changing political winds in Washington next year could be favorable for these stocks. Over the long term, these stocks could provide significant retirement income. Motley Fool Issues Rare “All In” Buy Alert
By: Keith Speights
Key Points American Express, Citigroup, and Capitol One Financial are Buffett stocks that are handily beating the S&P 500 this year. Only one of the three has an attractive dividend -- Citigroup. Each of these Buffett dividend stocks could outperform the market again in 2025. Motley Fool Issues Rare “All In” Buy Alert
By: Keith Speights, David Jagielski
Key Points AbbVie is a bargain. Novo Nordisk should have an exciting year ahead. Vertex Pharmaceuticals seems likely to enjoy an end-of-year rebound. Motley Fool Issues Rare “All In” Buy Alert
By: Keith Speights
Key Points Broadcom's stock price has nearly doubled in 2024, and it could still have a little more room to run if analysts are right. Nvidia is enjoying another spectacular year as Wall Street eagerly anticipates more sales growth from its newest GPUs. Motley Fool Issues Rare “All In” Buy Alert
By: Keith Speights
Could Donald Trump Fix Social Security's Biggest Problem in 2025?
By: Keith Speights
Key Points This high-conviction stock has roughly doubled the return of the S&P 500 so far in 2024. The stock's strong sales growth and rapidly increasing profitability have been key factors behind its success. All of the factors behind its outperformance this year remain in place going into 2025. Motley Fool Issues Rare “All In” Buy Alert
(833) 317-6278 
